Global Tuberculosis Therapeutics Market Size to Exceed USD 6.49 Billion by 2033 | CAGR of 5.75%
Category: HealthcareGlobal Tuberculosis Therapeutics Market to Exceed USD 6.49 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Tuberculosis Therapeutics Market Size Expected to Grow from USD 3.71 Billion in 2023 to USD 6.49 Billion by 2033, at a CAGR of 5.75% during the forecast period 2023-2033.
Get more details on this report -
Browse 210 market data Tables and 45 Figures spread through 220 Pages and in-depth TOC on the Global Tuberculosis Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Therapy (First-Line Therapy and Second-Line Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/tuberculosis-therapeutics-market
The market for tuberculosis therapeutics includes the development, manufacturing, and distribution of medications and therapies intended to combat tuberculosis (TB). With medicines designed to address both drug-resistant and drug-susceptible forms of the disease, this market focuses on treating both latent and active tuberculosis. The pharmaceutical industry's expansion and improvements in the manufacturing of anti-TB treatments, which are brought about by the increasing prevalence of tuberculosis, also generate a market potential for TB treatment products. It is anticipated that more clinical trials of new drugs by major companies globally and more product approvals of various anti-TB medicines will positively affect market expansion. The need for strong anti-TB drugs is also being fueled by the rising number of TB patients, which is driving the market's growth. However, the market's growth is being constrained by the high costs associated with treating the ailment. MDR TB is a major global public health concern. An estimated half a million MDR TB1 cases, many of which are extremely drug-resistant, are expected to occur annually around the world.
- The second-line therapy segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe. .
On the basis of therapy, the global tuberculosis therapeutics market is categorized as first-line therapy and second-line therapy. Among these, the second-line therapy segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe.The second-line therapy category is expected to have a considerable market share over the forecast period, owing to increased national tracking efforts, rising MDR TB prevalence, and global programs sponsored by the WHO and the Global Drug Facility (GDF).
- The hospital pharmacy segment accounted for the highest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of distribution channel, the global tuberculosis therapeutics market is categorized as hospital pharmacy, retail pharmacy, and online pharmacy. Among these, the hospital pharmacy segment accounted for the highest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. Pharmacists and hospital pharmacies are significant players in the industry since they oversee pharmaceuticals in a critical hospital environment where prompt access to supplies and prescription drugs is essential.
North America is projected to hold the largest share of the global tuberculosis therapeutics market over the forecast period.
Get more details on this report -
North America is projected to hold the largest share of the global tuberculosis therapeutics market over the forecast period. North America dominates the market for anti-tuberculosis treatments because of the region's growing R&D activity and rising healthcare spending, both of which will quicken the market's rate of expansion. The increasing usage of the Bacillus Calmette-Guérin (BCG) vaccine will also affect the market's growth rate in this area.
Europe is expected to grow at the fastest CAGR growth of the global tuberculosis therapeutics market during the forecast period. The market is expected to grow during the forecast period due to a number of factors, including the growth in drug-resistant TB cases, higher investments in the development of anti-TB agents, and the number of new medications being developed to treat TB infections. The growth of the tuberculosis treatment drug industry is also fueled by the educational camps held by various private organizations to increase awareness of the diagnostic, prevention, and treatment options available globally.
Major vendors in the global tuberculosis therapeutics market are AstraZeneca, Johnson & Johnson Services, Inc., Eli Lilly and Company, Viatris Inc. (formerly Mylan N.V.), Teva Pharmaceutical Industries, Ltd., Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Pfizer Inc. and Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In October 2022, the Aurum Institute, Unitaid, the Clinton Health Access Initiative (CHAI), and other global procurement organisations have inked a deal with Lupin Limited to promote the launch of two novel fixed-dose formulas for the treatment of tuberculosis prevention. 138 countries will receive these formulations, many of which are low- and middle-income countries with significant TB burdens.
Market Segment
- This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global tuberculosis therapeutics market based on the below-mentioned segments:
Global Tuberculosis Therapeutics Market, By Therapy
- First-Line Therapy
- Second-Line Therapy
Global Tuberculosis Therapeutics Market, By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Tuberculosis Therapeutics Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?